SEC Tracker
Get the app

Inspire Medical Systems INSP

Inspire Medical Systems reported Q3 2026 results

Item 2.02 Reports results, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. Third quarter revenue of $206.7 million
  2. Diluted EPS of $(0.84); adjusted diluted EPS of $0.14
  3. Operating cash flow of $46.4 million
  4. AMA approved new CPT codes for single lead hypoglossal nerve stimulation

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Inspire Medical Systems files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Masimo MASI public float $3.9B, Jun 28, 2025
  2. Integer Holdings ITGR public float $4.3B, Jun 27, 2025
  3. TransMedics Group TMDX public float $4.4B, Jun 30, 2025
  4. Icu Medical ICUI public float $3.2B, Jun 30, 2025
  5. PROCEPT BioRobotics PRCT public float $3.2B, Jun 30, 2025